ECDC together with the Latvian national authorities and the EU Health Task Force (EUHTF), completed an After-Action Review (AAR) to strengthen future preparedness and response to leptospirosis and other zoonotic disease outbreaks.
An agency of the European Union
Frequent searches:
ECDC together with the Latvian national authorities and the EU Health Task Force (EUHTF), completed an After-Action Review (AAR) to strengthen future preparedness and response to leptospirosis and other zoonotic disease outbreaks.
On 17 March 2026, ECDC supported a simulation exercise in Brussels, Belgium, designed to explore cross-sectoral collaboration and coordination when responding to a potential viral haemorrhagic fever outbreak.
Every month ECDC provides detailed epidemiological overview of the worldwide transmission of chikungunya virus disease in its weekly threat report (Communicable Diseases Threat Report).
ECDC regularly assesses new evidence on variants detected through epidemic intelligence, rules-based genomic variant screening or other scientific sources.
ECDC cooperates with international partners, such as the World Health Organization and the centres for disease control and prevention (CDCs) across the globe.
ECDC monitors social media for epidemic intelligence purposes. This is done by monitoring a list of predefined users using Epidemic Intelligence from Open Sources (EIOS) and monitoring a list of predefined users on social media platforms.
The purpose of the Audit Committee is to assist the Management Board in fulfilling its oversight responsibilities for the financial reporting process, the system of internal control and the audit process.
In 2026, there have been 32 729 CHIKVD cases and nine associated deaths reported worldwide.
Cases have decreased when compared to the same period in 2025.
Since the beginning of 2026, and as of 23 March 2026, over 500 000 cases of dengue and over 100 dengue-related deaths had been reported globally, according to information from publicly available sources. This is a decrease compared to the same period in 2025.
Every month ECDC provides detailed epidemiological overview of the worldwide transmission of dengue in its weekly threat report (Communicable Diseases Threat Report).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14-20 March 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, chikungunya, dengue, avian influenza, invasive meningococcal disease, aedes aegypti detection in Luxembourg, and measles.
Communicable disease threats report, 21 – 27 March 2026, Week 13
English (3.67 MB - PDF)
This interactive dashboard provides a weekly integrated epidemiological summary for influenza, RSV and SARS-CoV-2.
This page includes the selection committees that have been appointed for the ongoing selection procedures.
Most respiratory viruses are declining across the EU/EEA: Influenza circulation and hospitalisations are decreasing. SARS CoV 2 activity is low. RSV activity remains elevated, with children under five years the most affected.
The European Centre for Disease Prevention and Control (ECDC) hosted a joint workshop, bringing together ECDC Management Board members and ECDC National Focal Points for Preparedness and Response to take stock of progress with the Public Health Emergency Preparedness Assessments* (PHEPA) that are being conducted by ECDC across the European Union/European Economic Area (EU/EEA) countries.
The Management Board approves and monitors the implementation of ECDC’s work programme and budget, it adopts its annual report and accounts - all in all, it acts as the governing body of the Centre.
A human case of avian influenza A(H9N2) infection in a returning traveller from a non-European country where the virus has previously been identified in birds, has been reported in the Lombardy region of Italy. This is the first human case of avian influenza A(H9N2) reported in the EU/EEA.
This overview presents key recommendations based on updates submitted by EU/EEA countries in 2023 regarding prevention, preparedness, response planning, and implementation at national level.
ECDC’s new practical guide offers detailed instructions for designing and conducting in-action and after-action reviews to strengthen Europe’s public health emergency preparedness and response.
In-action reviews (IARs) and after-action reviews (AARs) – referred to collectively in this guide as ‘action reviews’ – provide a structured way to capture and act on the lessons learned during an ongoing or past public health emergency response.
Guide for designing and conducting in-action and after-action reviews
English (5.86 MB - PDF)
Workshop under the EU-funded Health Resilience in the Eastern Partnership project aim to help countries turn lessons from the COVID-19 pandemic into practical actions for stronger, more resilient public health laboratories.
Reporting protocol for submitting data on antimicrobial consumption to ECDC, through the European Antimicrobial Consumption Surveillance Network (ESAC-Net).
Tuberculosis remains a significant public health challenge in Europe, despite often being considered a disease of the past.
Dashboard showing the countries that still have remaining cases of WPV, and also those with cases of circulating vaccine derived polio virus (cVPDV).
Tuberculosis (TB) is a major cause of morbidity and mortality in Europe. High-quality laboratory diagnosis of TB is the basis for both individual patient treatment and surveillance.
Handbook on tuberculosis laboratory diagnostic methods in the European Union - updated 2026
English (5.31 MB - PDF)